Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Young GLP-1 DrugsSeptember 19, 2024 Obesity-Drug Pioneers Win Prestigious Lasker Award for Medical Science Three scientists are honored for developing a class of blockbuster weight-loss drugs
doi: 10.1007/s13679-017-0262-y
Research shows a strong inverted relationship between insulin resistance and sex-hormone binding globulin (SHBG)
Approval could enable healthcare providers to add retatrutide to their toolbox when treating obesity, particularly for individuals who have not responded to other treatments
Thalidomide a drug, perhaps known more for its controversial 1950s history as a sedative for pregnant women with morning sickness, which was withdrawn after it was found to lead to severe skeletal birth defects was repurposed and approved by the FDA about 60 years later for use in combination with dexamethasone in patients with newly diagnosed multiple myeloma
The dose may need to be re-evaluated after 6-12 months, but again, this is based on observed symptoms, not predictions
